|Articles|October 13, 2021
Best Practices Guide to Data Privacy in Clinical Trials
Author(s)Egnyte
As life sciences companies grow, the regulatory compliance requirements and risks expand as well. These responsibilities extend beyond conventional health-related frameworks (e.g. GxP, HIPAA, etc.) into the realm of data privacy. For high-growth institutions with limited resources & bandwidth, the question arises: what should you do? In this document, Egnyte chronicles some of the regulations affecting the life sciences industry and share 5 activities to help your organization comply with these new and dynamic laws.
Trending on Applied Clinical Trials Online
1
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
2
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
3
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5